Skip to main content
Premium Trial:

Request an Annual Quote

MSK Partners With Cota on Clinical, Genomic Data Sets

CHICAGO (GenomeWeb) – Healthcare analytics technology company Cota has entered into a partnership with New York's Memorial Sloan Kettering Cancer Center.

Cota will take anonymized clinical records from MSK and run it through its Cota Nodal Address classification system to build clinical and genomic data sets. This will have the dual purposes of supporting patient care and research at MSK and augmenting Cota's store of evidence.

Cota Nodal Address creates patient cohorts by categorizing patient-specific medical histories, information on their diseases, and planned therapies. "This organized and analyzed data will help our physicians practice more efficiently, optimizing the care a patient receives based on a variety of characteristics and ultimately can improve outcomes for all cancer patients as this knowledge is shared," Paul Sabbatini, MSK's deputy physician-in-chief for clinical research, said in a statement.

MSK and Cota — previously known as Cancer Outcomes Tracking and Analysis — also said that they would form an unspecified technology collaboration centered around analytics for improving disease classification in oncology.

"Cota's powerful technology platform can thread disparate data into a rich longitudinal record to support hypothesis testing, actionable insights, and evidence based decision-making," said Janhvi Patel, Cota's vice president of strategic partnerships. "This collaboration puts Cota at the forefront of precision medicine, creating one of the richest clinical and genomic databases in cancer to fuel innovation in research and development of new therapies and payer-provider value-based programs."

The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.